Pediatric obesity, obesity, child, adolescent, metabolic syndrome
Conditions
Interventions
Multiprofessional program of Obesity Treatment
Number of participants: 220 adolescents who are overweight, with 130 participants in the intervention group (IG) and 90 in the control group (CG).
Age
Behavioural
Sponsors
Universidade Estadual de Maringá
Fundação Araucária
Eligibility
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Adolescents classified with overweight or obesity according to the criteria established by Cole et. al (2000); concordance of the adolescent and his/her parents/guardians in participating integrally in the interventions.
Exclusion criteria
Exclusion criteria: The exclusion criteria were: endocrine and metabolic diseases previously diagnosed and informed to the pediatrician; long-term alcohol consumption; use of glucocorticoids and psychotropics which could affect appetite regulation; less than 70 % compliance in all multidisciplinary interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EXPECTED OUTCOME: Reducing body fat verified by bioelectrical impedance analysis device based on statistically significant difference (p <0.05), comparing the measures of the week before the beginning of the interventions and the one obtained on the next week after the completion of 16 weeks of intervention.;FOUND OUTCOME: Reducing body fat assessed by bioelectrical impedance analysis device, multifrequency, octapolar the InBody model 520 based on statistically significant differences (p <0.001), and the average pre-intervention 34.04 ± 10.50 kg and post intervention of 32.84 ± 10.84 kg.;EXPECTED OUTCOME: Reduction in the prevalence of metabolic syndrome (MS) based on the cutoff points for the International Diabetes Federation (IDF 2007) from the finding of a 15% reduction among the assessment performed in the week before the beginning of the interventions and one week after the completion of 16 weeks of intervention.;FOUND OUTCOME: Reduction in the prevalence of metabolic syndrome (MS) based on the cutoff points for the International Diabetes Federation (IDF 2007) from the finding of a 30% reduction in the prevalence of MS after 16 weeks of intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| EXPECTED OUTCOME: Increased cardiorespiratory fitness verified by the 20 meters Leger test based on statistical difference (p <0.05), among the average obtained on the week before the beginning of the interventions and the next week after the end of 16 weeks intervention.;FOUND OUTCOME: Increased cardiorespiratory fitness verified by the 20 meters Leger test based on statistical difference (p <0.001), between the average pre-intervention 24.70 ± 4.88 ml/kg/min and post intervention 26.70 ± 5.88 ml/kg/min.;EXPECTED OUTCOME: Improved quality of life related to health checked by the generic questionnaire PedsQLTM 4.0 based on statistically significant difference (p <0.05), among the evaluations being held the week before the beginning of the interventions and the next week after the end of 16 weeks intervention.;FOUND OUTCOME: Improved the quality of life related to health checked by the generic questionnaire PedsQLTM 4.0 based on statistically significant differences (p = 0.001), among the average pre-intervention 74.34 ± 14.15 and the post-intervention 78,24±11.97. | — |
Countries
Brazil
Contacts
Public ContactNelson Nardo Junior
Universidade Estadual de Maringá
Outcome results
None listed